|Year : 2020 | Volume
| Issue : 4 | Page : 623-626
Transient symptomatic zinc deficiency in a breastfed infant associated with low zinc levels in maternal serum and breast milk improving after zinc supplementation: An uncommon phenotype?
Sanket Vashist, Ashwani Rana, Vikram K Mahajan
Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Kangra, (Tanda), Himachal Pradesh, India
|Date of Web Publication||13-Jul-2020|
Vikram K Mahajan
Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Kangra, (Tanda) - 176 001, Himachal Pradesh
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Acrodermatitis enteropathica (AE) is a rare, autosomal-recessive disorder of neonatal zinc deficiency due to SLC39A4 (intestinal zinc transporter, Zip4) gene mutation with onset after weaning while breastfeeding during this period will be protective. Transient symptomatic zinc deficiency is also acquired rarely in breastfed infants with increased zinc requirements and/or inadequate concentration of zinc in breast milk. The nursing mothers of transient symptomatic zinc deficiency infants show SLC30A2 (mammary epithelial zinc transporter, ZnT-2) gene mutation and abnormally low zinc levels in the breast milk despite normal serum zinc levels, which do not improve after zinc supplementation. A 2-month-old breastfed male infant had AE-like clinical features of zinc deficiency for two weeks. His symptoms and low serum zinc levels improved rapidly after zinc supplementation. The mother also had low serum and breast milk zinc concentration and both improved after oral zinc therapy indicating a non-heritable phenotype. The relevant literature is reviewed and significance of dietary zinc supplementation during pregnancy/lactation is emphasized.
Keywords: Acrodermatitis enteropathica, breastfed-infant, dietary zinc, hypozincemia, lactation, zinc
|How to cite this article:|
Vashist S, Rana A, Mahajan VK. Transient symptomatic zinc deficiency in a breastfed infant associated with low zinc levels in maternal serum and breast milk improving after zinc supplementation: An uncommon phenotype?. Indian Dermatol Online J 2020;11:623-6
|How to cite this URL:|
Vashist S, Rana A, Mahajan VK. Transient symptomatic zinc deficiency in a breastfed infant associated with low zinc levels in maternal serum and breast milk improving after zinc supplementation: An uncommon phenotype?. Indian Dermatol Online J [serial online] 2020 [cited 2021 May 11];11:623-6. Available from: https://www.idoj.in/text.asp?2020/11/4/623/276579
| Introduction|| |
Zinc deficiency in infancy in its classic form is known as acrodermatitis enteropathica (AE). It is a rare autosomal-recessive disorder of impaired intestinal zinc absorption due to mutations in SLC39A4 gene mapped to 8q24.3 chromosome encoding Zip4 zinc transporter essential for intestinal absorption of zinc.,, It manifests clinically after weaning and is characterized by polymorphic lesions (eczematous, oozy, vesicular, bullous, pustular, burnt skin-like, psoriasiform) and/or erosive plaques with characteristic crusted edges involving skin around body orifices and over extremities accompanying with paronychia, angular cheilitis, dry and brittle hair and alopecia, diarrhea, delayed wound healing, and increased susceptibility to infections particularly for Staphylococcus aureus and Candida albicans., Photophobia, anemia, anorexia, hypogeusia, nail dystrophy, failure to thrive, delayed growth and puberty, and male hypogonadism ensue or it may end fatally in untreated cases. On the other hand, more frequent is transient symptomatic zinc deficiency in first few months occurring in premature or low birth weight infants because of inadequate neonatal stores, high requirement, or sometimes from prolonged parenteral alimentation. Other uncommon cause of transient symptomatic zinc deficiency in breastfed infants has been described secondary to abnormally low zinc levels in the breast milk despite normal serum zinc levels in nursing mother., Zinc deficiency whether inherited or acquired has identical clinical features, which are mainly due to low zinc levels and clinical improvement is rapid, within days to weeks, after zinc replacement therapy. While AE needs lifelong treatment, treatment duration in transient neonatal zinc deficiency without relapses depends upon breastfeeding at weaning. The described case is of a breastfed infant with transient symptomatic zinc deficiency having AE-like clinical features and low serum zinc levels responding rapidly to zinc supplementation. The mother had low serum and breast milk zinc levels which improved after zinc supplementation. The relevant literature is also reviewed.
| Case Report|| |
A 2-month-old male infant was hospitalized with progressive, multiple erythematous, crusted, and glazed dermatitic lesions predominantly involving buttocks, perianal area, scrotum and prepuce [Figure 1]a, cheeks, chin, pinnae, neck fold, and nostrils [Figure 1]b symmetrically for 15 days suggestive of acrodermatitis enteropathica. Few similar lesions were also distributed widely over trunk and extremities, fingers [Figure 1]c, ankles, and popliteal fossae. Historically, initial lesions had developed over perianal skin and involved other sites within a week. He had poor sleep, 4-5 loose stools per day, and aversion for feeds for past 1 week. He was first child born normally to otherwise healthy non-consanguineous parents after an uneventful gestation and full-term pregnancy. No similar problem was reported in any other family offsprings. He was exclusively breastfed, weighed 4.5 kg, immunized for his age, and had normal mental and developmental milestones. He was afebrile, irritable, had minimal pallor, oral thrush, photophobia, and paronychia. He had no lymphadenopathy, hair or nail abnormality. Systemic examination and baseline laboratory investigations showed no significant abnormality [Table 1]. KOH mount and aerobic culture from skin lesions showed no fungus or bacterial growth. His serum zinc levels were 0.8μg/dl (normal 70–115 μg/dl) estimated colorimetrically (ERBACHEM-7 Spectrophotometer) by nitro-PAPS (2-(5-nitro-2-pyridylazo)-5-(N-propyl-N-sulfopropylamino) phenol) method usingin vitro kits from AGAPPE Diagnostics Ltd., India. The zinc levels in mother's serum were 12 μg/dl (normal 70–115 μg/dl) and 14 μg/dl in the breast milk (normal 16.0–536.0 μg/dl, median 166.0 μg/dl at two months of postpartum). Her complete blood counts and serum biochemistry including serum calcium (9.2 mg/dl), magnesium (2.1 mg/dl), albumin (3.9 gdl), and alkaline phosphatase (88 U//l) levels were within the reference range.
|Figure 1: (a) Extensive, sharply-defined, symmetrical, erythema with erosions with glazed surfaceand secondary yellowish-brownish crusts in diaper region. Burnt skin-like appearance with black crusting at the margins is characteristic. Note scrotal involvement and lesions over back. Similar lesions were over extremities. (b): Multiple erythematous vesiculopustules and crusted plaques of variable size over both cheeks, around the mouth and nostrils, and neck fold. Note characteristic expressionof irritability. (c): Lesions over digits and paronychia|
Click here to view
Treatment with oral zinc 1 mg/kg/day of elemental zinc (zinc gluconate oral solution containing elemental zinc ≡ 4 mg/ml) in two divided doses was initiated overnight along with bland emollients topically. Mother was also given elemental zinc (1 mg/kg/day) orally as zinc sulfate 220 mg ≡ 50 mg elemental zinc, and advised to continue breastfeeding. Clinical symptoms of irritability, photophobia, diarrhea, sleep, and acceptance for feed improved rapidly by next morning after first dose itself. The serum zinc levels improved to 8.2 μg/dl after 2 doses of oral zinc. His skin lesions resolved completely [Figure 2]a, [Figure 2]b, [Figure 2]c] and serum zinc levels were 110 μg/dl after 1 week at discharge from hospital. The serum and milk zinc levels in mother also improved to 166 μg/dl and 160 μg/dl, respectively, after 1 week of zinc supplementation. The baby was completely normal on follow-up visit after 2 months. Both had discontinued zinc supplementation a month after leaving the hospital. However, zinc levels in serum or breast milk could not be re-estimated. The mother was advised to wean the baby at 6 month onwards. They did not follow-up further.
|Figure 2: (a) Completely resolved lesions at 1 week after zinc supplementation. The child has become playful. (b): Mild residual erythema on the cheeks and (c) diaper area|
Click here to view
| Discussion|| |
Zinc is an essential micronutrient for humans that form vital component of over 2000 transcription factors and more than 300 metallo-enzymes (carbonic anhydrase, alkaline phosphatase, alcohol dehydrogenase, RNA polymerases). Its significance as a micronutrient vital for growth, development, and immune function and its supplementation in low birth weight infants and children is well recognized now. Although neonatal hepatic stores of zinc from intrauterine life are sufficient to meet the demand during 4–6 months of postnatal life, this may not happen for premature or small-for-gestation infants because of their poor neonatal zinc stores. The zinc nutrition, mostly from breast milk, in first 3 months postnatally is adequate. However breast milk zinc concentration, which is highest during early period of lactation, declines sharply during the first 3 months and steadily through 7months and thereafter coinciding with weaning but the infant's requirement increases leading to deficiency states unless zinc is supplemented in daily dietary intake.,
Acquired transient zinc deficiency in breastfed infant due to low zinc concentration in breast milk of nursing mothers that does not improve despite zinc supplementation is attributed to a mutation in the SLC30A2 gene mapped to chromosome 1p36.11 encoding ZnT-2 zinc transporter in humans.,, It is associated with low mammary epithelial zinc transport in mother and is different from lethal milk mice due to murine SLC30A4 gene mutation (ZnT-4)., Recently, Lee et al. demonstrated that genetic variants in SLC30A2 (ZnT-2) mutation have profound consequences on zinc pools. This affects key cellular functions in mammary epithelial cells that may lead to breast dysfunction and decreased secretion of zinc into breast milk which otherwise contains adequate zinc for infantile requirements up to 6 months. Reported cases suggest that this defect is perhaps inherited as an autosomal recessive or X-linked disorder. However, the genetic defect in mother mostly remains unrecognized although she represents a classic genotype and low milk zinc phenotype while the symptomatic presentation is exclusive to the breastfed infant as was also observed in our case having classic transient zinc deficiency and mother showing no signs of zinc deficiency despite very low serum zinc concentration. Although we could not perform genetic studies, the absence of consanguinity and similar problem in other family offsprings, improvement of low maternal serum and breast milk zinc concentrations after zinc supplementation, and rapid therapeutic response without recurrence in our case despite discontinuing zinc supplement short while after clinical improvement are distinct and indicative of a sporadic non-inherited phenotype. Wherein, the maternal intake of low zinc-diet during pregnancy and post partum period with consequent low serum and milk zinc concentration in her remains distinctly possible in view of prevailing social taboos and customs of dietary restrictions during pregnancy and lactation when zinc requirement increases almost two folds. However, mother showing no clinical signs despite very low serum zinc concentrations and how low maternal intake will influence milk zinc concentrations remains less understood as studies reviewed to understand regulation of zinc metabolism and effect of nutrition and non-dietary or other host factors on this complex process have remained inconclusive. Studies involving well-nourished populations show no direct correlation between milk zinc concentration and maternal dietary zinc intake, whereas data from low zinc consuming populations have shown low mean milk zinc concentrations., It has been suggested that in mild-to-moderate maternal zinc deficiency, reduced milk zinc output is perhaps a maternal adjustment to chronic intake of diet low in zinc. And we tend to agree.
Although long-term follow-up is imperative in such cases to draw any conclusion, the need of maternal zinc supplementation during pregnancy/lactation and role it has in infant's optimum growth and development are emphasized.
All authors declare that they have no competing interest and therefore nothing to declare, and have contributed significantly and take full responsibility for the manuscript. The authors of the paper are obliged to confirm that it has not been previously published.
SV obtained, compiled, and analyzed all data and prepared initial draft. AR helped in data obtaining, compiling, and literature search. VKM analyzed and interpreted data, edited, and critically evaluated the manuscript for important intellectual content. All authors were involved in the revision of the draft manuscript and have agreed to the final content.
Statement of ethics
Informed consent was obtained from parents for publication of material with the understanding that name and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975 as revised in 2013.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient/parents have given their consent for images and other clinical information to be reported in the journal. The patient/parents understand that his name and initials will not be published and due efforts will be made to conceal his identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Wang K, Pugh EW, Griffen S, Doheny KF, Mostafa WZ, Al-Aboosi MM, et al.
Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3. Am J Hum Genet 2001;68:1055-60.
Küry S, Kharfi M, Kamoun R, Taieb A, Mallet E, Baudon JJ, et al
. Mutation spectrum of human SLC39A4 in a panel of patients with acrodermatitis enteropathica. Human Mut 2003;22:337-8.
Schmitt S, Küry S, Giraud M, Dréno B, Kharfi M, Bézieau S. An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica. Hum Mutat 2009;30:926-33.
Perafán-Riveros C, França LF, Alves AC, Sanches JA Jr. Acrodermatitis enteropathica: Case report and review of the literature. Pediatr Dermatol 2002;19:426-31.
Maverakis E, Fung MA, Lynch PJ, Draznin M, Mchael DJ, Ruben B, et al
. Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol 2007;56:116-24.
Kiechl-Kohlendorfer U, Fink FM, Steichen-Gersdorf E. Transient symptomatic zinc deficiency in a breast-fed preterm infant. Pediatr Dermatol 2007;24:536-40.
Zattra E, Belloni Fortina A. Transient symptomatic zinc deficiency resembling acrodermatitis enteropathica in a breastfed premature infant: Case report and brief review of the literature. G Ital Dermatol Venereol 2013;148:699-702.
Coelho S, Fernandes B, Reis JP, Moreno A, Figueiredo A. Transient zinc deficiency in a breast-fed, premature infant. Eur J Dermatol 2006;16:193-5.
Dorea JG. Zinc in human milk. Nutr Res 2000;20:1645-87.
Gupta M, Mahajan VK, Mehta KS, Chauhan PS. Zinc therapy in dermatology: A review. Dermatol Res Pract 2014;2014;709152. doi: 10.1155/2014/709152.
Hambidge KM, Miller LV, Krebs NF. Physiological requirements for zinc. Int J Vitam Nutr Res 2011;81:72-8.
Krebs NF, Westcott JL, Rodden DJ, Ferguson KW, Miller LV, Hambidge KM. Exchangeable zinc pool size at birth is smaller in small-for-gestational-age than in appropriate-for-gestational-age preterm infants. Am J Clin Nutr2006;84:1340-3.
Kerb N. Zinc transfer to breastfed infant. J Mamm Gland Bio Neoplasia 1999;4:259-68.
Sharma NL, Sharma R, Gupta KR, Sharma R, Mahajan VK. Hypozincemia in infancy. Indian J Dermatol Venereol Leprol 1985;51:256-60.
] [Full text]
Chowanadisai W, Lönnerdal B, Kelleher SL. Identification of a mutation in SLC30A2(ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J Biol Chem 2006;281:39699-707.
Michalczyk A, Varigos G, Catto-Smith A, Blomeley RC, Ackland ML. Analysis of zinc transporter, hZnT4 (Slc30A4), gene expression in a mammary gland disorder leading to reduced zinc secretion into milk. Hum Genet 2003;113:202-10.
Lee S, Zhou Y, Gill DL, Kelleher SL. A genetic variant in SLC30A2 causes breast dysfunction during lactation by inducing ER stress, oxidative stress and epithelial barrier defects. Sci Rep 2018;8:3542.
Kelleher SL, Seo YA, Lopez V. Mammary gland zinc metabolism: Regulation and dysregulation. Genes Nutr 2009;4:83-94.
[Figure 1], [Figure 1], [Figure 1], [Figure 2]
[Table 1], [Table 1]